Correlation Between Recursion Pharmaceuticals and 456837AQ6
Specify exactly 2 symbols:
By analyzing existing cross correlation between Recursion Pharmaceuticals and ING GROEP NV, you can compare the effects of market volatilities on Recursion Pharmaceuticals and 456837AQ6 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of 456837AQ6. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and 456837AQ6.
Diversification Opportunities for Recursion Pharmaceuticals and 456837AQ6
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Recursion and 456837AQ6 is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and ING GROEP NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ING GROEP NV and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with 456837AQ6. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ING GROEP NV has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and 456837AQ6 go up and down completely randomly.
Pair Corralation between Recursion Pharmaceuticals and 456837AQ6
Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to under-perform the 456837AQ6. In addition to that, Recursion Pharmaceuticals is 16.32 times more volatile than ING GROEP NV. It trades about -0.04 of its total potential returns per unit of risk. ING GROEP NV is currently generating about 0.0 per unit of volatility. If you would invest 9,532 in ING GROEP NV on September 22, 2024 and sell it today you would lose (16.00) from holding ING GROEP NV or give up 0.17% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 85.04% |
Values | Daily Returns |
Recursion Pharmaceuticals vs. ING GROEP NV
Performance |
Timeline |
Recursion Pharmaceuticals |
ING GROEP NV |
Recursion Pharmaceuticals and 456837AQ6 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Recursion Pharmaceuticals and 456837AQ6
The main advantage of trading using opposite Recursion Pharmaceuticals and 456837AQ6 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, 456837AQ6 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 456837AQ6 will offset losses from the drop in 456837AQ6's long position.Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |